Literature DB >> 8353921

Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.

V Dilsizian1, P Perrone-Filardi, J A Arrighi, S L Bacharach, A A Quyyumi, N M Freedman, R O Bonow.   

Abstract

BACKGROUND: Stress thallium scintigraphy provides important diagnostic and prognostic information in patients with coronary artery disease by demonstrating regional myocardial ischemia. However, if the clinical question being addressed is whether a region is viable and not whether there is inducible ischemia, then it may be more reasonable to perform rest-redistribution imaging rather than stress-redistribution imaging followed by either reinjection or late redistribution. Therefore, we determined whether stress-redistribution-reinjection and rest-redistribution imaging provide the same information regarding myocardial viability. METHODS AND
RESULTS: Both stress-redistribution-reinjection and rest-redistribution thallium single photon emission computed tomographic imaging was performed in 41 patients with chronic stable coronary artery disease, with quantitative analysis of regional thallium activity. Thallium reinjection was performed immediately after the 3- to 4-hour redistribution images were completed. Of the 155 myocardial regions with perfusion defects on the stress images, 91 (59%) were irreversible on conventional 3- to 4-hour redistribution images. When the outcomes of these irreversible regions were assessed after reinjection and compared with rest-redistribution images, there was concordance of data regarding myocardial viability (normal/reversible or irreversible) in 72 of the 91 (79%) irreversible defects. Twenty of the 41 patients also underwent positron emission tomography at rest with [18F]fluorodeoxyglucose and [15O]water. In these patients, stress-redistribution-reinjection and rest-redistribution imaging provided concordant information regarding myocardial viability in 427 (72%) of 594 myocardial regions and discordance in 167 regions. However, when irreversible thallium defects were further analyzed according to the severity of the thallium defect in these discordant regions, 149 of 167 (89%) demonstrated only mild-to-moderate reduction in thallium activity (51% to 85% of normal activity), and positron emission tomography verified 98% of these regions to be metabolically active and viable. Thus, when the severity of thallium activity was considered within irreversible thallium defects, the concordance between stress-redistribution-reinjection and rest-redistribution imaging regarding myocardial viability increased to 94%.
CONCLUSIONS: These data indicate that one of two imaging modalities, either stress-redistribution-reinjection or rest-redistribution imaging, may be used for identifying viable myocardium. However, if there are no contraindications to stress testing, stress-redistribution-reinjection imaging provides a more comprehensive assessment of the extent and severity of coronary artery disease by demonstrating regional myocardial ischemia without jeopardizing information on myocardial viability.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353921     DOI: 10.1161/01.cir.88.3.941

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  31 in total

1.  Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct artery.

Authors:  M Faraggi; G Montalescot; L Sarda; J F Heintz; D Doumit; G Drobinski; I Sotirov; D Le Guludec; D Thomas
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

Review 2.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

3.  Myocardial perfusion and function single photon emission computed tomography.

Authors:  Christopher L Hansen; Richard A Goldstein; Daniel S Berman; Keith B Churchwell; C David Cooke; James R Corbett; S James Cullom; Seth T Dahlberg; James R Galt; Ravi K Garg; Gary V Heller; Mark C Hyun; Lynne L Johnson; April Mann; Benjamin D McCallister; Raymond Taillefer; R Parker Ward; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

4.  Stress radionuclide studies after acute myocardial infarction: changes with revascularization.

Authors:  I Coma-Canella; M del Val Gómez; L Salazar; F Gallardo
Journal:  J Nucl Cardiol       Date:  1996 Sep-Oct       Impact factor: 5.952

5.  Reinjection of thallium for detection of viable myocardium: why not do it immediately?

Authors:  B L van Eck-Smit; E E van der Wall
Journal:  Br Heart J       Date:  1995-08

6.  The extracellular matrix in hibernating myocardium--a significant factor causing structural defects and cardiac dysfunction.

Authors:  A Elsässer; M Schlepper; R Zimmermann; K D Müller; R Strasser; W P Klövekorn; J Schaper
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

7.  A challenge to the nuclear cardiology laboratory: imaging goals in patients after infarction.

Authors:  T P Rocco; M A Pfeffer
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

8.  Comparative accuracy of various Tl-201 reinjection imaging protocols to detect myocardial viability.

Authors:  H Naruse; T Kondo; T Arii; M Morita; M Ohyanagi; T Iwasaki; M Fukuchi
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

9.  Defect reversibility using thallium-201 reinjection. Comparison of stress-redistribution-reinjection with stress-immediate reinjection.

Authors:  B L van Eck-Smit; A F Kuijper; A H Zwinderman; A V Bruschke; E K Pauwels; E E van der Wall
Journal:  Int J Card Imaging       Date:  1996-03

10.  Dual-isotope myocardial imaging: feasibility, advantages and limitations. Preliminary report on 231 consecutive patients.

Authors:  P Weinmann; J M Foult; D Le Guludec; F Tamgac; D Rechtman; A Neuman; N Caillat-Vigneron; J L Moretti
Journal:  Eur J Nucl Med       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.